| Name | Title | Contact Details |
|---|
St. Luke`s, a regional health care system, offers a comprehensive continuum of care serving the 17-county region of northeastern Minnesota, northwestern Wisconsin and the Upper Peninsula of Michigan. The system includes St. Luke`s Hospital in Duluth, Minnesota, Lake View Hospital in Two Harbors, Minnesota, and 11 primary and 27 specialty clinics. Primary care clinics are located in Duluth, Hermantown, Hibbing, Two Harbors, Mountain Iron and Silver Bay, Minnesota, and Ashland and Superior, Wisconsin. Urgent care and Q Care express medical services are also available. St. Luke`s is designated by the American College of Surgeons and the state of Minnesota Department of Health as a Level II trauma center. St. Luke`s Regional Cancer Center offers treatments including Stereotactic Radiosurgery (SRS) and radiation oncology. St. Luke`s Regional Heart Center includes cardiology, cardiothoracic surgery, cardiac rehab services and catheterization lab. Other specialties include obstetrics, gynecology, plastic surgery, pulmonary medicine, allergy, neurosurgery, dermatology, endocrinology, gastroenterology, infectious disease, surgery, occupational health, orthopedics and sports medicine, pediatrics, physical medicine and rehab, rheumatology, psychiatry, urology, hospice and home care. With the University of Minnesota Duluth Medical School, St. Luke`s conducts clinical research in the areas of cancer, lung and heart disease through the Whiteside Institute for Clinical Research.
Garrett County Memorial Hospital offers a full range of inpatient services to meet the growing and changing needs of its area residents. Because GCMH is located in a beautiful rural setting, away from the hustle and bustle of city life, our professional,
Fenner Physician Svc Corp is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Sunrise Dental Lab is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.